{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-144151","form_type":"8-K","ticker":"LYRA","cik":"0001327273","company_name":"Lyra Therapeutics, Inc.","filed_at":"2025-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.949180+00:00","generated_at":"2026-05-18T23:25:00.534748+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Lyra regains Nasdaq minimum bid price compliance after 12-day streak above $1.00","bullets":["Received notice from Nasdaq on June 13, 2025, confirming compliance with Listing Rule 5550(a)(2).","Common stock maintained minimum bid price of $1.00 for 12 consecutive business days (May 28 - June 12, 2025).","The matter is now closed; no further action required from Nasdaq on this issue."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-144151","json":"https://secwatch.observer/filing/0001193125-25-144151.json","markdown":"https://secwatch.observer/filing/0001193125-25-144151.md","text":"https://secwatch.observer/filing/0001193125-25-144151.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1327273/000119312525144151/0001193125-25-144151-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1327273/000119312525144151/d857375d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T23:25:00.534748+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}